Related Experiment Videos
Vasopressin during abdominal hysterectomy: a randomized controlled trial
C R Okin1, R S Guido, L A Meyn
1University of Pittsburgh, Magee-Women's Hospital, Pittsburgh, Pennsylvania 15213, USA.
Obstetrics and Gynecology
|June 1, 2001
Summary
Vasopressin injection significantly reduces blood loss during abdominal hysterectomy by 40%. This method is a safe and effective adjunct for gynecological surgery, minimizing complications.
Area of Science:
- Gynecology
- Surgical Innovation
Background:
- Abdominal hysterectomy is a common procedure for uterine leiomyomas.
- Excessive blood loss remains a significant surgical concern during hysterectomy.
Purpose of the Study:
- To evaluate the efficacy of intraoperative vasopressin injection in reducing blood loss during abdominal hysterectomy.
- To assess the safety profile of vasopressin when used as an adjunct in this surgical setting.
Main Methods:
- A randomized controlled trial involving 51 patients with leiomyomatous uterus undergoing abdominal hysterectomy.
- Patients received either vasopressin (10 units) or normal saline placebo, injected into the lower uterine segment.
- Blood loss was quantified, and statistical analysis was performed to compare outcomes between groups.
Main Results:
- The vasopressin group experienced a mean blood loss of 445.41 mL, compared to 748.42 mL in the placebo group.
- Intrauterine vasopressin injection resulted in a significant 40% reduction in total blood loss (P <.001).
- No significant differences in surgical complications or confounding variables were observed between the vasopressin and placebo groups.
Conclusions:
- Intrauterine vasopressin injection is a safe and effective method to significantly decrease blood loss during abdominal hysterectomy.
- Vasopressin serves as a valuable adjunct, improving surgical outcomes by minimizing hemorrhage without increasing patient morbidity.